H.R. 5133

To amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.

House · 2 versions on the shelf

Print stage	Date	Size	⠃
Introduced in House	2019-11-18	12.2K	⠃⠗⠋
Reported in House	2020-12-24	12.5K	⠃⠗⠋